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a  b  s  t  r  a  c  t
Cyclophosphamide  (CP)  is a widely  used  cytotoxic  alkylating  agent  with  antitumor  and  immunosuppres-
sant  properties  that  is associated  with  various  forms  of reproductive  toxicity.  The  signiﬁcance  of natural
antioxidants  of  plant  origin  should  be  explored,  especially  in  a world  with  increasing  incidence  of  patients
in  need  of  chemotherapy.  The  neuro-endocrine  effects  of  aqueous  extract  of Amaranthus  viridis  (Linn.)
leaf  (AEAVL)  in Wistar  rats  with  CP-induced  reproductive  toxicity  was  determined.  Forty  rats  were  used
for this  study  such  that  graded  doses  of  the  extract  were  administered  following  CP-induced  reproductive
toxicity  and comparisons  were made  against  control,  toxic  and  standard  (vitamin  E) groups  at p  <  0.05.  The
synthetic  drugs  (CP,  65  mg/kg  i.p. for  5 days;  Vitamin  E,  100  mg/kg  p.o.  for 30 days)  as well  as  the  extract
(100,  200  and  400  mg/kg  p.o. for  30 days)  were  administered  to the  rats at  0.2 mL/100  g. CP induced  repro-
ductive  toxicity  as evidenced  by signiﬁcantly  lowered  levels  of  FSH,  LH  and  testosterone,  perturbation
of  sperm  characterization,  deleterious  disruptions  of the antioxidant  system  as  evidenced  by decreased
levels  of  GSH  as  well  as  elevation  of  TBARS  activity.  Histopathological  examination  showed  hemorrhagic
lesions  with  scanty  and hypertrophied  parenchymal  cells  in  the  pituitary  while  the  testis  showed  bal-
looned  seminiferous  tubules  with  loosed  connective  tissues  and  vacuolation  of testicular  interstitium.
These  conditions  were  signiﬁcantly  reversed  (p <  0.05)  following  administration  of the  graded  doses  of
the extract.  It was,  therefore,  concluded  that AEAVL  could  potentially  be a  therapeutic  choice  in  patients
with  CP-induced  neuro-endocrine  dysfunction  and  reproductive  toxicity.
©  2016  Published  by  Elsevier  Ireland  Ltd.  This is an  open  access  article  under the CC  BY-NC-ND. Introduction
Reproductive toxicity is the occurrence of biologically adverse
ffects on the reproductive system of living organisms that may
esult from exposure to environmental agents or xenobiotics. The
oxicity may  be expressed as alterations to the reproductive organs,
elated endocrine system and or pregnancy outcomes [1]. Accord-
ng to existing literatures, the use of anticancer drugs affects aspects
f reproductive function, including fertility, in both human and
xperimental animals [2–4]. CP is a widely used cytotoxic alkylat-
ng agent with antitumor and immunosuppressant properties [5]. It
s used for the treatment of various forms of cancer such as chronic
∗ Corresponding author at: Department of Physiological Sciences, Obafemi
wolowo University, Ile-Ife, Osun State, Nigeria.
E-mail address: staywithchris@gmail.com (E.C. Imaﬁdon).
ttp://dx.doi.org/10.1016/j.toxrep.2016.07.007
214-7500/© 2016 Published by Elsevier Ireland Ltd. This is an open access article under license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
and acute leukemia, multiple myeloma, lymphomas, rheumatic
arthritis and systemic lupus erythematosus [5]. It is also used as an
immunosuppressive agent for organ transplantation [5]. However,
CP treatment is associated with various forms of reproductive toxi-
city despite its wide spectrum of clinical use [6]. Due to severe toxic
and undesirable side effects in multiple organ systems, there is a
gradual but increasing limitation to the use of this drug for cancer
chemotherapy [6,7]. It is therefore imperative to develop strategies
that are geared towards minimizing the side effects of this appar-
ently health-beneﬁcial drug in a world of increasing incidence of
patients in need of chemotherapy.
Vitamin E, a group of compounds comprising both tocotrienols
and tocopherols, is a lipid-soluble antioxidant that protects cell
membranes from oxidation by reacting with lipid radicals that
are produced in the lipid peroxidation chain reaction as well as
expresses its antioxidant functions in the glutathione peroxidase
pathway [8–10]. Its most biologically active form is alpha toco-
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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herol [8,11] and is apparently a conventional drug used in the
melioration of xenobiotics-induced reproductive toxicity in ani-
al  models [12–14].
The pathophysiology of CP has implicated both oxidative stress
nd reactive oxygen species (ROS) generation [15–17]. ROS plays a
ritical role in the pathological mechanism of male reproductive
ysfunction [7,18]. These proposed pathophysiological mecha-
isms of CP point towards the fact (hypothesis) that treatment
ith a potent antioxidant can possibly help reverse or amelio-
ate its toxic effects. This study aimed at engaging ethno-botanical
pproach to test this hypothesis since plant derived medicines,
esides their easy availability and being relatively cheaper for the
ffordability of a common man, is relatively safer than the synthetic
lternatives [19] and has been used as a source of inspiration for
he development of novel drugs [20].
Amaranthus viridis (Linn.) is an annual herb of the family Ama-
anthaceae [21]. In Nigeria, it is commonly called “green leaf”
r “tete” amongst the Yoruba tribe. The plant is erect, having
tems that are up to about 10–100 cm in length with branched
labrous leaves. In Greek, Amaranthus is translated as “never-
ading ﬂower”. In the light of modern research, the various parts
f the plant have been explored for health-boosting potentials.
n traditional medicine, powdered seeds of the ﬂower have been
hown to possess health beneﬁcial effects such as treatment of
tomach problems [22] and reduction of labour pain in preg-
ant women [23]. The stems have potent anti-diuretic potentials
hile the traditional use of the leaves range from anti-diabetic,
nti-rheumatic, laxative, diuretic, analgesic agent as well as an
nti-inﬂammatory agent used in the treatment of asthma, eye and
espiratory dysfunctions [24–26]. Also, the plant experimentally
valuated for antioxidant, anti-hyperlipidemia and anti-diabetic
roperties [27,28], anti-nociceptive [29], hepatoprotective [30] as
ell as antipyretic and analgesic activities [31].
Despite the experimental evidences portraying a wide range
f its health-beneﬁcial effects, our literature survey revealed that
till date) there is no experimental evidence of this plant, Ama-
anthus viridis (Linn.), effects on the neuro-endocrine function in
n animal model of drug-induced reproductive toxicity. In order
o bridge this gap in knowledge, this study was  embarked upon
o assess the neuro-endocrine effects of the aqueous extract of
maranthus viridis (Linn.) leaf (AEAVL) in male Wistar rats with
yclophosphamide-induced reproductive toxicity.
. Materials and methods
.1. Plant material, drug and biochemical kits
Fresh leaves of Amaranthus viridis were obtained from the Farm
ouse of the Department of Crop Science and Production, Faculty
f Agricultural Science, Obafemi Awolowo University (OAU), Ile Ife,
sun State, and certiﬁed by a Taxonomist in the Department of
otany, OAU, Ile-Ife; where a voucher specimen (IFE − 17424) was
eposited.
Salt of cyclophosphamide (CP) was purchased from Zuvius Life-
ciences Pvt. Ltd, Mumbai, India while th kits for hormone assay
ere purchased from Monobind Inc., Lake Forest CA 92630, USA
Accu-Bind Elisa Microwells).
.2. Plant extraction
Fresh leaves of Amaranthus viridis were air-dried, pulverized
ith an Electric Pulverizer (DIK-2910, Daiki Rika Kogyo Co. Ltd,
okyo-Japan) and thereafter macerated in water. This mixture was
ubjected to constant shaking for a period of 24 h with the aid
f an Electric Shaker and afterwards ﬁltered under vacuum usingports 3 (2016) 608–619 609
Buchner funnel and Whatman number 2 Filter Paper (Whatman
PLC, Middlesex, UK). The ﬁltrate was  concentrated under vacuum
using a Rotary Evaporator (HahnShin Scientiﬁc, HS-2005-N) and
thereafter freeze-dried in a Lyophilizer (Ilshin Lab. Co. Ltd, Seoul,
Republic of Korea). The resulting yield was  kept in a desiccator until
when needed.
2.3. Detection and quantiﬁcation of phytochemicals
Alkaloids were qualitatively determined by the method of Halilu
and coworkers [32] and quantiﬁed as described by Harbone [33].
Also, the presence of ﬂavonoids was determined by the method
of Halilu and coworkers [32] and quantiﬁed by the method of
Obadoni and Ochuko [34]. Tannins was qualitatively determined
by the method of Halilu and coworkers [32] and thereafter quan-
tiﬁed by the method of Allen and coworkers [35]. Saponins were
qualitatively determined using Froth test as described by Benmehdi
and coworkers [36] and quantitatively screened by the method of
Obadoni and Ochuko [34]. Quantitative determination of cardiac
glycosides was  by Keller-Kiliani test as described by [37] Anjali and
Sheetal. This was thereafter quantiﬁed by the method of Harbone
[35].
2.4. Stock solutions of cyclophosphamide and aqueous extract of
amaranthus viridis (Linn.) leaf
Sixty ﬁve (65) mg/kg stock solution of cyclophosphamide (CP)
was prepared as follows; 500 mg  of CP salt was dissolved in 15 mL
of distilled water and administered at 0.2 mL/100 g rat per day via
intraperitoneal route. Thus
each 100 g rat received 6.5 mg  of CP per day; an equivalent of
65 mg/kg/day of CP.
The extract’s stock solution for 100 mg/kg was prepared by dis-
solving 1 g of AEAVL in 20 mL  of distilled water. Consequently, every
100 g rat received 0.2 mL  of the extract to prevent the deleterious
effects of ﬂuid overload. Accordingly, stock solutions for 200 mg/kg
and 400 mg/kg of AEAVL were prepared by dissolving 2 g and 4 g of
the extract, respectively, each in 20 mL  of distilled water.
2.5. Animal management and experimental design
All experimental protocols were in strict compliance with the
guidelines for animal research, as detailed in the NIH Guidelines
for the Care and Use of Laboratory Animals [38] and approved by
local Institutional Research Committee. Forty (40) male Wistar rats
of about 3 months of age, weighing 150–180 g, were used for this
study. They were purchased from the Animal Holdings of the Col-
lege of Health Sciences, OAU, Ile − Ife, Osun State, Nigeria where the
study was carried out. They were housed in plastic cages under nat-
ural light and dark cycle and allowed access to standard laboratory
rat chow (Caps Feed PLC Osogbo, Nigeria) and water ad libitum.
The rats were divided into eight groups of ﬁve rats (n = 5) each as
follows; Group 1 (Control) received distilled water (0.2 mL/100 g)
intraperitoneally for 5 days and thereafter left for a period of
30 days after which they were sacriﬁced. Group 2 (Toxic) received
65 mg/kg of cyclophosphamide (CP) intraperitoneally for 5 consec-
utive days after which they were sacriﬁced. Group 3 (CP + Recovery)
were pretreated as group 2 and thereafter left for a recovery period
of 30 days after which they were sacriﬁced. Group 4 (CP + Vitamin E)
were pretreated as group 2 and thereafter received 100 mg/kg/day
Vitamin E via oral route for 30 days after which they were sacriﬁced.
Groups 5, 6 and 7 were each pretreated as group 2 and there-
after received graded doses of aqueous extract of Amaranthus viridis
(Linn.) leaf (AEAVL) at 100, 200 and 400 mg/kg/day respectively via
oral route for 30 days after which they were sacriﬁced. Group 8
received AEAVL (only) at 200 mg/kg/day for 30 days and thereafter
610 O.A. Ayoka et al. / Toxicology Reports 3 (2016) 608–619
Fig. 1. Experimental Protocol and Dose Regimen.
G s); G5 = Group 5 (5rats); G6 = Group 6 (5rats); G7 = Group 7 (5rats); G8 = Group 8 (5rats);
R f Ama
s
a
s
a
8
u
p
−
a
f
t
h
w
H
s
2
s
b
u
t
c
[1 = Group 1 (5rats); G2 = Group 2 (5rats); G3 = Group 3 (5rats); G4 = Group 4 (5rat
P  = Recovery Period; P.O. = Par Oral; Vit. E = Vitamin E; AEAVL = Aqueous Extract o
acriﬁced (Fig. 1). At the end of the study, the rats were euthanized
nd their blood samples were collected by cardiac puncture into
eparate EDTA bottles.
The blood samples were centrifuged at 4000 rpm for 15 min
t −4 ◦C using a cold centrifuge (Centurium Scientiﬁc, Model
881). Plasma obtained was decanted into separate plain bottles
sing sterile syringes. Assessment of reproductive hormones in the
lasma obtained was carried out using appropriate kits by Enzyme
 Linked Immuno Sorbent Assay (ELISA) technique.
The procedures for hormone assay were as provided in the
ppropriate kits. The left caudal epididymis of each rat was care-
ully excised to obtain semen for sperm characterization. While
he left testis and 1 g of each rat’s brain were kept in a cooler for
omogenate preparation, the right testis and pituitary of each rat
ere ﬁxed in Bouin’s ﬂuid and 10% formal-saline respectively, for
istopathological examination using Hematoxylin − Eosin (H & E)
taining technique.
.6. Measurement of body and organ weight
Assessment of weekly weight change was carried out using Han-
on digital weighing balance (Hanson, China) to measure weekly
ody weight. On the other hand, organ weights were determined
sing Camry sensitive weighing balance (Camry, China). The rela-
ive testicular weight, relative brain weight and percentage weight
hange were calculated using the formulae below;
Relative Testicular Weight (RTW)%
= Left testis+Right testis (g)
Final body weight (at point of sacriﬁce) g
x 100%
39]Relative Brain Weight (RBW)%
= Whole brain (g)
Final body weight (at point of sacriﬁce) g
x 100%ranthus viridis (Linn.) Leaf; * = Point that rats were sacriﬁced.
[39]
Percentage Weight Change (PWC)%
= (Final body weight − Initial body weight) g
Initial body weight (g)
x  100%
[39]
2.7. Sperm characterization
Semen from the caudal epididymis was released onto a
microscope slide and sperm counts were carried out using hemo-
cytometer and expressed as million per milliliter of suspension.
The epididymal sperm motility was assessed by calculating motile
spermatozoa per unit area and expressed as motility in percent-
age. By the method of Bloom and Fawcett [40], sperm viability was
determined after preparing uniform smear spermatozoa on slides
using Eosin − Nigrosin stain.
2.8. Hormone assays
The plasma levels of follicle stimulating hormone, luteinizing
hormone and testosterone were determined using the standard
laboratory protocols that were provided in the appropriate (afore-
mentioned) kits. The adopted technique was  Enzyme − Linked
Immuno Sorbent Assay (ELISA).
2.9. Assessment of oxidative stress indicators
Using an electric homogenizer (SI601001), 10% homogenate in
phosphate buffer (100 mM)  was prepared with the tissues at pH of
7.4. The homogenate was centrifuged at 3000 rpm for 20 min  and
the supernatant was  collected for the assessment of the following
indicators of oxidative stress;Reduced glutathione (GSH) level was determined by the method
of Beutler and coworkers [41] while the activity of Thiobarbituric
Acid Reactive Substances (TBARS) was  determined as described by
Ohkawa and coworkers [42].
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Table  1
Qualitative and Quantitative Screening of Aqueous Extract of Amaranthus viridis
(Linn.) Leaf.
Phytochemical
Constituents
Status Percentage
Composition (g/100 g)
Alkaloids + 14.25 ± 0.92
Flavonoids + 51.0 ± 0.47
Tannins + 8.80 ± 0.69
Saponins − nil
Cardiac Glycoside + 63.20 ± 0.92
Each value (n = 3) is expressed as mean ± Standard Error of Mean; + = present;
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.10. Histopathological examination
The pituitary and testis of each rat were dehydrated in graded
lcohol and embedded in parafﬁn wax. Sections >4 m thick were
tained with Hematoxylin − Eosin and thereafter viewed under a
eica DM750 camera. Photomicrographs of the testis were taken at
agniﬁcations of ×40, ×100 and ×400 while that of the pituitary
as taken at ×400 only.
.11. Statistical analysis
Data obtained were expressed as mean ± Standard Error of Mean
sing one-way analysis of variance. These were thereafter sub-
ected to Bonferonni’s post-hoc test and level of signiﬁcance was
et at p < 0.05. Graph pad prism 5.03 (Graph Pad Software Inc., CA,
SA) statistical package was used for the statistical analysis of the
ata obtained.
. Results
.1. Phytochemical analysis
Except for saponins that were absent, the phytochemical screen-
ng of the extract showed the presence of alkaloids, ﬂavonoids,
annins and cardiac glycoside (Table 1).
.2. Sperm counts [SC (millions/mL)], sperm motility [SM (%)] and
perm viability [SV (%)]
While group 8 (AEAVL only) showed no signiﬁcant difference in
C when compared with group 1 (control) (p < 0.05), groups 2–7
ere signiﬁcantly reduced when compared with group 1 (p < 0.05).
he AEAVL-treated groups 5, 6 and 7 showed a signiﬁcantly higher
mount of SC when compared with both group 2 (toxic) and group
 (toxic + recovery) (p < 0.05). There was no signiﬁcant difference
etween the AEAVL-treated groups 5, 6 and 7 when compared with
roup 4 (CP + vitamin E) (p < 0.05). Group 3 never recovered from
he signiﬁcant decrease in SC when compared with groups 1 and 2
p < 0.05). This trend was shown to be consistent with SV (Table 2).
The result for SM showed no signiﬁcant difference between
roups 8 and 1 (p < 0.05). However, while groups 4–7 showed no
igniﬁcant difference in SM when compared with group 2 (p < 0.05),
M was found to be signiﬁcantly higher in these groups (4–7) when
ompared with group 3 (p < 0.05). At the end of the study, no signif-
cant difference was recorded between the AEAVL-treated groups
–7 when compared with group 4 (CP + vitamin E) (p < 0.05). Group never recovered from the signiﬁcant decrease in SM when com-
ared with groups 1 and 2 (p < 0.05) (Table 2). Ta
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.3. Relative testicular weight [RTW (%)], relative brain weight
RBW (%)] and percentage weight change [PWC (%)]
There was no signiﬁcant difference in RTW of the AEAVL-treated
roups 5, 6 and 7 when compared with group 1 (control) (p < 0.05).
lso, group 8 (AEAVL only) showed no signiﬁcant difference in RTW
hen compared with group 1 (p < 0.05). Groups 2, 3 and 4 showed
 signiﬁcantly higher RTW when compared with group 1 (p < 0.05).
t the end of the study, except for group 5 that was signiﬁcantly
ower than group 3 alone, the AEAVL-treated groups 6 and 7 showed
 signiﬁcantly lower RTW when compared with groups 2 and 3
p < 0.05) (Table 3).
With the exception of group 8, groups 2–7 showed a signiﬁ-
antly lower RBW when compared with group 1 (p < 0.05). The
EAVL-treated groups 5–7 showed a signiﬁcantly higher RBW
hen compared with groups 3 and 4 (p < 0.05). There was  no signif-
cant difference in the AEAVL-treated groups 5–7 when compared
ith group 4 (p < 0.05) (Table 3).
Groups 2–4 showed a signiﬁcantly lower PWC  when compared
ith group 1 (p < 0.05). However, group 8 showed no signiﬁcant dif-
erence when compared with group 1 (p < 0.05). The AEAVL-treated
roups 5–7 showed a signiﬁcantly higher PWC  when compared
ith group 3 (p < 0.05). Group 3 (CP + Recovery) never recovered
rom the weight loss when compared with groups 1 and 2 (p < 0.05)
Table 3).
.4. Plasma levels of follicle stimulating hormone [FSH (mIU/mL)],
uteinizing hormone [LH (mIU/mL)] and testosterone (ng/mL)
Plasma FSH level was signiﬁcantly lowered in groups 2–7 when
ompared with group 1 (p < 0.05). However, group 8 showed no sig-
iﬁcant difference when compared with group 1 (p < 0.05). There
as a signiﬁcantly higher level of plasma FSH in the AEAVL-treated
roups 5–7 when compared with groups 2 and 3 (p < 0.05). Group
 never recovered from the signiﬁcantly lowered plasma FSH level
hen compared with groups 1 and 2 (p < 0.05). This result is con-
istent with that of LH (Fig. 2).
The result showed a signiﬁcantly lowered plasma testosterone
evel in groups 2–7 when compared with group 1 (p < 0.05). Group
 recorded no signiﬁcant difference when compared with group
 (p < 0.05). AEAVL-treated groups 6 and 7 showed a signiﬁcantly
igher level of plasma testosterone when compared with groups 2
nd 3 (p < 0.05) while group 5 was signiﬁcantly higher than group
 only (p < 0.05). Group 6 showed a signiﬁcantly higher level when
ompared with group 4 (p < 0.05) while group 3 never recovered
rom the signiﬁcantly lowered level when compared with groups 1
nd 2 (p < 0.05) (Fig. 2).
.5. Reduced glutathione (GSH) levels in the brain (g/mg
rotein) and testis (g/mg protein)
GSH level was signiﬁcantly lowered in the brain homogenate
f groups 2–7 when compared with group 1 (p < 0.05). This was
hown to be signiﬁcantly higher in groups 4–7 when compared
ith groups 2 and 3 (p < 0.05). Group 3 never recovered from the
igniﬁcantly lowered GSH level in the brain when compared with
roup 2 (p < 0.05). At the end of the study, group 8 showed no sig-
iﬁcant difference when compared with group 1 (p < 0.05) (Fig. 3).
Groups 2 and 3 showed signiﬁcantly lowered levels of testic-
lar GSH when compared with group 1 (p < 0.05). However, the
EAVL-treated groups 5–7 showed signiﬁcantly higher levels of
esticular GSH when compared with both groups 2 and 3 (p < 0.05).
hile group 8 showed no signiﬁcant difference when compared
ith group 1 (p < 0.05), group 3 never recovered from the signiﬁ- Ta
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Fig. 2. Effects of AEAVL on Plasma [a.] Follicle Stimulating Hormone (mIU/mL), [b.] Luteinizing Hormone (mIU/mL) and [c.] Testosterone (ng/mL) Levels in Male Wistar Rats
with  Cyclophosphamide-Induced Reproductive Toxicity.
A.  = Aqueous Extract of Amaranthus viridis (Linn.) Leaves (AEAVL); FSH = Follicle Stimulating Hormone; LH = Luteinizing Hormone. Each bar represents mean ± Standard Error
of  Mean (n = 5); * = signiﬁcantly different from group 1 (Control) at p < 0.05;  = signiﬁcantly different from group 2 (Toxic) at p < 0.05;  = signiﬁcantly different from group
3  (CP + Recovery) at p < 0.05;  = signiﬁcantly different from group 4 (CP + Vitamin E) at p < 0.05.
Fig. 3. Effects of AEAVL on [a.] Testis Reduced Glutathione (g/mg protein) [b.] Brain Reduced Glutathione (g/mg protein) Levels in Male Wistar Rats with Cyclophosphamide-
Induced Reproductive Toxicity.
A lutat
d 2 (Tox

c
2
3
t
2
A
a
a. = Aqueous Extract of Amaranthus viridis (Linn.) Leaves (AEAVL); GSH = Reduced G
ifferent from group 1 (Control) at p < 0.05;  = signiﬁcantly different from group 
 = signiﬁcantly different from group 4 (CP + Vitamin E) at p < 0.05.
antly lowered testis GSH level when compared with groups 1 and
 (p < 0.05) (Fig. 3).
.6. Activity of thiobarbituric acid reactive substances (TBARS) in
he brain (nmol/mg protein) and testis (nmol/mg protein)
TBARS activity was signiﬁcantly higher in the brain of groups
, 3 and 5 when compared with group 1 (p < 0.05). However, the
EAVL-treated groups 5–7 recorded a signiﬁcantly lower TBARS
ctivity when compared with groups 2 and 3 (p < 0.05). Group 4
lso showed a signiﬁcantly lower TBARS activity when comparedhione. Each bar represents mean ± Standard Error of Mean (n = 5); * = signiﬁcantly
ic) at p < 0.05;  = signiﬁcantly different from group 3 (CP + Recovery) at p < 0.05;
with groups 2 and 3 (p < 0.05). Group 3 never recovered from the
signiﬁcantly lowered activity of TBARS when compared with group
2, while group 8 showed no signiﬁcant difference when compared
with group 1 (p < 0.05) (Fig. 4).
TBARS activity in the testis was signiﬁcantly higher in groups 2
and 3 when compared with group 1 (p < 0.05). Except for group 6
that showed signiﬁcantly lower activity of TBARS when compared
with group 2, the AEAVL-treated groups 5–7 showed a signiﬁ-
cantly lower level of TBARS activity when compared with group
3 (p < 0.05). At the end of the study, group 8 showed no signiﬁcant
difference in TBARS activity when compared with group 1 (p < 0.05)
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Fig. 4. Effects of AEAVL on [a.] Testes TBARS (nmol/mg protein) [b.] Brain TBARS (nmol/mg protein) Activities in Male Wistar Rats with Cyclophosphamide-Induced Repro-
ductive Toxicity.
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s. = Aqueous Extract of Amaranthus viridis (Linn.) Leaves (AEAVL); TBARS = Thiobarbi
 = signiﬁcantly different from group 1 (Control) at p < 0.05;  = signiﬁcantly differen
t  p < 0.05;  = signiﬁcantly different from group 4 (CP + Vitamin E) at p < 0.05.
hile group 3 never recovered from the signiﬁcantly increased
BARS activity when compared with both groups 1 and 2 (p < 0.05)
Fig. 4).
.7. Histopathological examination
.7.1. Pituitary
Slide [1] shows normal histoarchitecture of parenchymal cells
n the interstitium of rat’s pituitary while slide [2] shows an area of
emorrhagic lesion and congestion of veins and capillaries (yellow
rrow). Also, parenchymal cells appear scanty and hypertrophied
black arrow) in slide [2].  There was evidence of severe hemorrhagic
esion (yellow arrow) in slide [3] while slide [4] shows focal area of
emorrhagic lesion (yellow arrow) with apparently hypertrophied
arenchymal cells (black arrow). Slides [5]–[7] show evidence of
mprovement in the histoarchitecture of the pituitary when com-
ared with slides [2] and [3].  However, in slide [5] there was
vidence of fat embolism (red arrow) with scanty parenchymal
ells while [6] showed evidence of scanty and hypertrophied cells
black arrow). Scanty and hypertrophied cells (black arrow) as well
s vacuolation of interstitial spaces in the pituitary (green arrow)
ere also distinct features in slide [7].  Slide [8] show similarity in
eatures as depicted in [1] (Fig. 5).
.7.2. Testis
Slide [1] shows evidence of apparently intact seminiferous
ubules as well as active cell division and maturation of the germ
ells as revealed by the presence of abundance of terminally dif-
erentiated cells/spermatozoa (green arrow). However, in slide [2]
here is evidence of poorly differentiated spermatozoa (thick black
rrow), ballooned and abnormally shaped/elongated seminiferous
ubules (thin black arrow) with loosed connective tissues and mild
acuolation of testicular interstitium (green arrow) while in slide
3] there was evidence of sloughing in the seminiferous epithe-
ium into the lumen, almost occluding it (double black arrow) as
ell as mild vacuolation of testicular interstitium (green arrow).
lide [4] shows hyperplasia of the leydig cells (red arrow) with
vidence of abnormally shaped/elongated seminiferous tubules
thin black arrow). Overall, the testicular histoarchitecture of the
epresentative AEAVL-treated groups [5]–[7] shows appreciable
mprovement when compared with the CP-induced histopathology
s depicted in [2] and [3].  Nevertheless, in slide [5] there is evi-
ence of hyperplasia of the leydig cells (red arrow) with ballooned
nd abnormally shaped/elongated seminiferous tubules (thin black
rrow). Slide [6] also has evidence of ballooned and abnormally
haped/elongated seminiferous tubules (thin black arrow) as wellcid Reactive Substances. Each bar represents mean ± Standard Error of Mean (n = 5);
 group 2 (Toxic) at p < 0.05;  = signiﬁcantly different from group 3 (CP + Recovery)
as inactive/inhibition of active cell division and maturation of germ
cells (double red arrow) while slide [7] has a focal area of mild
fatty inﬁltration of the seminiferous epithelium (double yellow
arrow), ballooned and abnormally shaped seminiferous tubules
(thin black arrow) and mild vacuolation of testicular interstitium
(green arrow). Slide [8] depicts similar testicular histoarchitecture
as shown in [1] (Fig. 6).
4. Discussion
The study investigated the neuro-endocrine effects of thirty
days administration of aqueous extract of Amaranthus viridis (Linn.)
leaves (AEAVL) in rats with cyclophosphamide-induced reproduc-
tive toxicity. There was  a comparative study of the effects of the
extract (AEAVL) and vitamin E on some reproductive indices of the
rats. Also, a dose of the extract (medium dose, only) was adminis-
tered to a group in order to appraise its effects on the reproductive
indices of study.
The signiﬁcantly lowered plasma FSH level that was associ-
ated with CP administration can be attributed to two factors; ﬁrst
is the deleterious alteration of the pituitary histoarchitecture (as
shown in the representative photomicrograph) with a consequent
decrease in pituitary FSH secretion and secondly, (subject to fur-
ther veriﬁcation) a possible decreased responsiveness of the sertoli
cells to the available plasma FSH. It is, however, not unlikely that
a possible proliferation of the spermatogonia via its active binding
with FSH was  altered by the decreased plasma level of testosterone
(possibly secondary to the reduced plasma LH level) that was asso-
ciated with CP administration. This was characterized by poorly
differentiated spermatozoa, as depicted by the representative pho-
tomicrograph. The representative plate also showed evidence of
vacuolation in both interstitium and seminiferous tubule. The
study therefore suggests that CP-induced reproductive toxicity is
expressed through injury inﬂicted on both the pituitary and testis
in rat model, secondary to oxidative stress. A body of literature
exists showing the fact that CP induces its deleterious effects in
biological systems principally by inducing oxidative stress through
generation of reactive oxygen species (ROS) [43–46]. Although,
administration of the extract was associated with reduced level
of reproductive hormones in the CP-exposed rat model when com-
pared with the control, the level was found to be signiﬁcantly higher
than that of the toxic group (toxicity model). This demonstrates the
fertility-boosting potential of the extract. Phytochemical screen-
ing of the extract was found to be rich in ﬂavonoids and tannins.
These phytochemicals are reputed to express potent antioxidant,
anti-inﬂammatory and anticancer potentials [47,48]. The restora-
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2] = Group 2, [3] = Group 3, [4] = Group 4, [5] = Group 5, [6] = Group 6, [7] = Group 7 
ive potential of the extract, characterized by improvements in the
istoarchitecture of the pituitary and testis as well as increase in
he level of reproductive hormones, may  be attributed to the pres-
nce of tannins and ﬂavonoids in it. It is, therefore, implied that
he extract has a promising therapeutic effect in rat model of CP-
nduced imbalance in the level of reproductive hormones.
Sperm counts provide information on the cumulative result of
ll stages in sperm production, making it one of the most reli-
ble sensitive tests for spermatogenesis with a high correlation
ith fertility [49,50]. The CP-induced decrease in sperm counts
emonstrated the impairment of reproductive function by delete-
ious interference of the critical stages of spermatogenesis. Hence,
he sperm counts-boosting potential of the extract in the CP-
xposed model suggests that one of its possible mechanisms of
ertility-boosting action is protection of the stages of spermatoge-
esis against the deleterious effects of xenobiotics such as drugs
nd chemicals that have the potential of inducing reproductive
oxicity. This could also have been achieved by the presence of
mportant phytochemicals (alkaloids, tannins and ﬂavonoids) with
otent antioxidant and, possibly, membrane-stabilizing potentials
hat are present in the extract. Considered as an integral part of
ome reproductive toxicity guidelines, assessment of sperm motil-
ty and viability is crucial in sperm characterization [51,52]. A
ompromise of reproductive function can be induced by a dele-
erious change of the microenvironment in the inner aspects of the
eminiferous tubules secondary to the permeation of blood-testis
arrier by chemical agents [53]. The representative photomicro-to Cyclophosphamide Toxicity.
 exposed to Cyclophosphamide toxicity. H & E staining (mg ×400). [1] = Group 1,
] = Group 8.
graph revealed evidence of luminal sloughing of the seminiferous
tubules with interstitial vacuolation. This may  explain the decrease
in sperm motility and viability that was associated with CP adminis-
tration. The study suggests that CP-induced reproductive toxicity is
enhanced by a possible permeation of blood-testis barrier to bring
about adverse alterations in the microenvironment of the seminif-
erous tubules. There was  a signiﬁcant boost of sperm motility and
viability in the extract-treated groups when compared with the
toxic model, although with values lesser than the control. A pos-
sible mechanism by which it achieves this is through its potential
to reinstate apparently normal antioxidant status in the testes by
blocking CP-induced assault as depicted by the indices of oxidative
stress that were assessed in this study. The deleterious alterations
in these indices of oxidative stress (GSH and TBARS) are evidences
of an assault to the reproductive tissue by the drug. This report
on deleterious alterations in sperm characterization following CP
administration in animal model is consistent with the ﬁndings of
Haubitz [54]; Abarikwu et al. [55]; Aroona et al. [46] and Divya et al.
[56].
The neurotoxic effects of CP have been reported by quite a
body of literature [44,45,57]. The representative photomicrograph
revealed evidence of severe hemorrhagic lesions as well as scanty
parenchymal cells in the pituitary (which could be non exclusive
to this region) during the period of CP administration. The sig-
niﬁcantly lowered relative brain weight (RBW) that was recorded
in this study can be attributed to a possible decrease in the total
number of cells that constitutes the brain tissue. This is subject to
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urther veriﬁcation. The extract was able to block this alteration via
, possibly, tissue regenerative mechanism; as the representative
hotomicrograph revealed restoration of lost parenchymal cells in
he pituitary. This could have been secondary to its antioxidant and
embrane stabilizing effects, potentiated by the presence of tan-
ins and ﬂavonoids in the extract. Contrariwise, CP administration
as associated with a signiﬁcant increase in the relative testicular
eight (RTW) of exposed rats. This can be attributed to the alter-
tion in structure of the seminiferous tubules which appeared to be
allooned and abnormally elongated instead of assuming its regular
void shape. Since the availability of testosterone in the circulation
s required for the growth, development and maintenance of male
eproductive organs [58], the promising but apparently incomplete
herapeutic effects of the extract on the RTW can be attributed to
ts testosterone-boosting potential which may  be secondary to its
ntioxidant effect.
Reduced glutathione (GSH) and Thiobarbituric acid reactive
ubstances (TBARS) are indices of antioxidant status in biological
ystems [59]. GSH, a measure of non-enzymatic antioxidant sta-
us, helps to effectively removes hydrogen peroxide and serves
s a cofactor for glutathione transferase, which helps to remove
ertain drugs, chemicals and other reactive molecules from cells
59,60]. TBARS is a measure of lipid peroxidation and oxidative
tress [59,60]. The decreased levels of GSH in both the pituitary
nd testis of CP-exposed rats can be attributed to its excessive
se by these tissues to scavenge the free radicals that were gen-
rated following CP intoxication and or decreased GSH production
ig. 6. Photomicrographs Showing the Effects of AEAVL on the Testis of Rats Exposed to C
hotomicrograph showing the effects of AEAVL administration on the testis of rats expos
olumn [B] = mg  ×100; Right column [C] = mg  ×400; [1] = Group 1, [2] = Group 2, [3] = Groports 3 (2016) 608–619
by these tissues. On the other hand, TBARS activity was  highly
increased in the pituitary and testis of exposed rats, indicating
high degree of lipid peroxidation and oxidative stress. Administra-
tion of the extract showed blocking of the CP-induced deleterious
alterations in the antioxidant homeostasis as evidenced by a signiﬁ-
cantly higher levels of GSH and signiﬁcantly lower levels of TBARS in
the extract-treated groups when compared with the toxicity model.
The study, therefore, demonstrated the antioxidant potential of the
extract.
The period of CP administration to the rats was characterized
by strange behaviors of isolation and depression; an expression of
neurotoxic effect. Deleterious alterations in feeding pattern were
also observed as feeds and water were almost untouched in the
feeding trough and drinkers respectively during this period. CP-
induced decrease in percentage weight change (PWC) of the rats
can be attributed to its neurotoxic effect. This may  have suppressed
the feeding center in the lateral hypothalamus [61] with a conse-
quent inhibition of appetite. A balance between dietary intake and
expenditure of energy is a determinant of weight gain or loss [61].
Therefore, the signiﬁcantly lowered PWC  can be attributed to the
deleterious alterations in feeding pattern that was observed. It is
not unlikely that the extract is rich in multivitamins and or contains
phytochemical(s) that mimics the appetite restorative capacity of
multivitamins as the depressive state of the rats was observed to
appreciably reduce following administration of the extract when
compared with the toxic model. This is worthy of further explo-
ration. Another possible explanation for the decrease in the PWC
yclophosphamide Toxicity.
ed to Cyclophosphamide toxicity. H & E staining, Left column [A] = mg ×40; Centre
up 3, [4] = Group 4, [5] = Group 5, [6] = Group 6, [7] = Group 7 and [8] = Group 8.
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s the corresponding decrease in the plasma testosterone level
hat was recorded during the study period. Plasma level of testos-
erone is responsible for the growth and development of male
exual organs as well as expression of sexual characters such as
he buildup of muscles [62,63]. Administration of the extract was
ssociated with testosterone-boosting potential in the CP-treated
ats.inued)
The group that received the extract alone (without CP) showed
similarities in biochemical indices as well as in sperm characteri-
zation when compared with the control. The same is true for their
histological examinations. This suggests that ingestion of aqueous
extract of Amaranthus viridis (Linn.) leaf does no potentiate dele-
terious effects on the neuro-endocrine or reproductive function of
apparently normal rats.
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The study showed that administration of Vitamin E alone may  be
nsufﬁcient in the management or treatment of reproductive toxic-
ty in CP-exposed subjects. Apparently, in animal model there seem
o be a standard reference of 100 mg/kg of vitamin E administration
n the treatment of drug- or chemically-induced reproductive toxi-
ity [13–15]. This study, however, showed that this dose-reference
id not prove much of a standard as shown in some of the repro-
uctive indices such as FSH and lipid peroxidation (TBARS) when
ompared with both the extract-treated groups and the control. A
eview of this apparently accepted dose is therefore suggested [64],
therwise its administration at this dose may  not be sufﬁcient to
roduce the desired or anticipated therapeutic effects in rat models
f CP-induced reproductive toxicity.
We  strongly recommend a study of the prophylactic effects of
he extract (AEAVL) in models of CP-induced reproductive toxicity.
t is imperative to conduct an advance study, at a molecular level,
ith a view to having a better understanding of the extract’s mech-
nism(s) of action. Also, there is need for future study of the extract
ractions for the biochemical basis of its therapeutic effects.
. Conclusion
In conclusion, the administration of aqueous extract of Ama-
anthus viridis (Linn.) leaf showed promising therapeutic effects
n male Wistar rat model of cyclophosphamide-induced neuro-
ndocrine dysfunction and reproductive toxicity. The extract could
otentially be a therapeutic choice in the management of subjects
ith cyclophosphamide-induced reproductive toxicity. Its thera-
eutic potential can at least be attributed to both its antioxidant
nd membrane stabilizing properties.
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